Kesimpta 20 MG/0.4 ML pen 0.4ML
Ended Awarded
- Contract number
- SPE2DB25FBJK3
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $36,220
Award facts
- Contract value 100% obligated
- $36,220.41 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $36,220.41 to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Kesimpta 20 mg/0.4 mL auto-injector pens. This is a firm fixed-price, non-set-aside contract with a completion date of September 16, 2025, and performance to be executed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999 prime vendor agreement extending through December 2026 that authorizes the company to supply pharmaceuticals and medical commodities globally to support military healthcare systems.
Kesimpta is a prescription medication used in the treatment of multiple sclerosis, reflecting the specialized pharmaceutical products that AmerisourceBergen supplies through its DLA contracts. As a major pharmaceutical distributor serving federal medical procurement needs, AmerisourceBergen regularly fulfills competitive delivery orders for brand-name and generic medications, vaccines, and medical supplies across multiple therapeutic domains for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This transaction exemplifies the company's role as a critical vendor within the Defense Logistics Agency's pharmaceutical supply chain supporting military and veteran healthcare operations.
Quick answers
Who was awarded contract SPE2DB25FBJK3?
SPE2DB25FBJK3 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 15, 2025.
How much is contract SPE2DB25FBJK3 worth?
The government has obligated $36,220 on SPE2DB25FBJK3.
Is contract SPE2DB25FBJK3 an order under another contract?
Yes. SPE2DB25FBJK3 is a delivery order under SPE2DB22D3016, an indefinite delivery contract.
Was contract SPE2DB25FBJK3 competed?
The extent of competition for SPE2DB25FBJK3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award